Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy
This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.
Suwon, Gyeonggi-doAges 19 years+ - NCT07836088Recruiting
Ultrasound muscle check for metabolic health
This study uses ultrasound scans to measure muscle mass in people with metabolic conditions like type 2 diabetes and obesity. It may help doctors understand how these conditions affect muscles and could lead to better care.
Zhangzhou, FujianAges 18 years+ - NCT07835308RecruitingEarly Phase 1
Smart tuning of brain stimulation for better walking
This study is testing a new way to adjust deep brain stimulation (DBS) settings to improve walking in people with Parkinson's disease. If you have DBS and can walk with stimulation off, this trial may help fine-tune your treatment to improve your gait.
Minneapolis, MinnesotaAges 18 years+ - NCT07837375Recruiting
Physical activity support app for COPD patients
This study tests a mobile app that helps people with COPD exercise more safely, possibly by giving them better tips and reminders. It aims to see if the app can improve their daily activity and overall wellbeing.
MontivilliersAges 18 years+ - NCT07826429Recruiting
Testing a new breathing mask for sleep apnea
This study tests a new style of breathing mask (called the F&P Licorice Mask) for people who already use CPAP or similar therapy for sleep apnea. You'll use the mask at home and give feedback on how it feels and works, which could help make future masks more comfortable.
St Louis, MissouriAges 22 years+ - NCT07826767RecruitingPhase 1/Phase 2
Gene therapy for inherited immune disease
This trial tests a new gene therapy (SGX-001) for chronic granulomatous disease caused by a specific genetic change. The treatment tries to fix the gene in your immune cells so they can fight infections better, and the trial will follow participants for up to 15 years to make sure it's safe and effective.
UlmAges 1.5 years+ - NCT06463717Recruiting
Stem cell transplant timing for multiple myeloma with no cancer cells left
This trial looks at people with newly diagnosed multiple myeloma who have no detectable cancer cells after initial treatment. It aims to see if these patients can do well without a stem cell transplant or with a delayed one, reducing unnecessary side effects.
Hangzhou, ZhejiangAges 18–70 - NCT07831681Recruiting
A therapeutic game for teens with psychotic symptoms
This trial tests whether a collaborative video game can help reduce psychiatric symptoms like delusions and hallucinations in teenagers. It may also help with rigid thinking, and could be a new way to support mental health during outpatient care.
RennesAges 12–17 - NCT07827716RecruitingPhase 2
Testing terfenadine for relapsing multiple sclerosis
This study tests whether terfenadine, an allergy medicine, is safe and helpful for people with relapsing-remitting multiple sclerosis (MS). It may reduce MS activity and improve outcomes.
Wuhan, HubeiAges 18–65 - NCT06477549RecruitingPhase 2
Comparing Two Drug Combinations for Stem Cell Transplant
This study compares two different drug combinations (BeFluBu and FluBuRux) used before a stem cell transplant from a half-matched (haploidentical) donor. The goal is to see which combination works better to prepare your body for the transplant and control your blood cancer.
Saint PetersburgAges 18–75 - NCT07822269Recruiting
Magnifying tools for deep teeth cleaning
This study compares two types of magnifying tools used during deep cleaning of teeth and gums. It aims to see if one tool is better at removing plaque and tartar, which may help treat gum disease.
AnkaraAges 18 years+ - NCT07818239Enrolling by invitation
How diet affects eye blood vessels
This study looks at how different foods and drinks affect the blood vessels in your eyes. By taking pictures of your retina (the back of the eye) after certain meals, researchers hope to learn more about diet and eye health.
ViennaAges 18 years+ - NCT07822737Recruiting
Using CT scans to find high-risk heart plaque
This study uses a special CT scan to look at the inside of your heart arteries and find any high-risk fatty deposits (plaque) that might cause problems later. It aims to see if this scan can predict future heart events, so you and your doctor can make better treatment choices.
Beijing, ChinaAges 18 years+ - NCT07822230Recruiting
Dietary guidance for reducing menopause symptoms in overweight women
This trial tests whether a diet based on Brazilian dietary guidelines can help reduce menopause symptoms (like hot flashes and mood changes) in overweight or obese women. If you're in this stage and looking for non-medical ways to feel better, this study might be a good fit.
Porto Alegre, Rio Grande do SulAges 40–65 - NCT07825831Recruiting
Personalized heat-risk alerts for chronic conditions
This study uses AI to send personalized heat warnings to people with chronic health conditions like high blood pressure, diabetes, or obesity. The goal is to help you avoid heat-related health problems during the six-week program.
Gujranwala, Punjab ProvinceAges 18 years+ - NCT07820644Recruiting
Liver cancer risk prediction in chronic liver disease
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
Shenzhen, GuangdongAges 18–75 - NCT07823842Recruiting
Biologics for asthma and COPD
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05352178RecruitingPhase 3
Targeted treatment for few-spread prostate cancer spots
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
LeuvenAges 18 years+ - NCT05870475RecruitingPhase 2
Interferon plus ruxolitinib for hydroxyurea-resistant polycythemia vera
This Phase 2 trial tests a combination of pegylated interferon and ruxolitinib in adults with polycythemia vera who can’t tolerate hydroxyurea or don’t respond well to it. If you qualify, it may help control blood counts and disease symptoms when standard treatment hasn’t worked.
TianjinAges 18 years+ - NCT06483347RecruitingPhase 2
Immunotherapy combo for inoperable lung cancer
This trial tests a combination of immunotherapy drugs (checkpoint inhibitors) delivered directly into the liver along with standard treatment, as a first option for people with inoperable lung cancer. It aims to see if this approach can help shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT07812831Enrolling by invitation
How health information changes over time
This study looks at how health information from people changes over time. The goal is to better understand normal patterns and spot when things change, which may help doctors improve care. You can join whether you have a medical condition or are generally healthy.
New York, New YorkAges 18 years+ - NCT06489808RecruitingPhase 2
Linperlisib plus chemoimmunotherapy for relapsed large B-cell lymphoma
This trial tests a drug called linperlisib combined with standard chemotherapy and immunotherapy for people with large B-cell lymphoma that has come back or not responded to one prior treatment.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05817734Recruiting
Research study to collect health information from adults
This is a research study that collects information about your health and traits to better understand human health and variation. It is mainly for adults who can consent and do not have several specific medical situations listed below.
RehovotAges 18 years+ - NCT07804316Recruiting
Food choice app for chronic kidney disease patients
This study tests a mobile app that helps people with chronic kidney disease (CKD) make healthier food choices. It aims to empower you to manage your condition better through daily food tracking and personalized guidance.
SingaporeAges 21 years+
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,559 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.